Stellaromics Inc. · 1 day ago
Vice President, Assay Development
Boston, MA
Full-time
Onsite
Director/Executive
$220K/yr - $270K/yr
10+ years expStellaromics Inc. is an innovative biotech startup founded in 2022, located in Boston, MA, focused on advancing biomedical research through proprietary technology. They are seeking a VP of Assay Development to lead the vision and execution of their assay portfolio, ensuring product alignment with market needs and high-quality performance.
3D TechnologyBiotechnology
Responsibilities
Define, champion, and execute a clear, compelling 3-5 year technical vision and product roadmap for the Pyxa/STARmap assay portfolio, ensuring alignment with commercial goals and market needs
Lead a focused effort on continuous data quality and robustness improvement of our STARmap and RIBOmap assays, ensuring we meet or exceed commercial specifications (e.g., sensitivity, reproducibility, dynamic range)
Direct the use of creative targeted assay development methods, rigorous Design of Experiments (DoE), and other statistical analysis to systematically improve assay performance, reduce variability, and ensure high reliability during scale-up
Provide authoritative technical guidance on all aspects of the assay, including complex molecular biology, nucleic acid chemistry, genomics, and multiplexed imaging protocols
Function as the ultimate technical authority for deep root cause analysis and troubleshooting, combining biological, chemical, and engineering perspectives to solve challenging development problems
Establish and enforce best practices for assay documentation, technology transfer (Tech Transfer) to Manufacturing, and formal design control processes required for a commercial-stage product
Build, mentor, and inspire a high-performing Assay Development team, fostering a culture of accountability, scientific rigor, and urgency
Serve as a key leader and team player in the organization, collaborating closely with Engineering (platform integration), Manufacturing (process transfer), R&D (new technology), and Product Management (customer specs) to ensure seamless product delivery
Manage department budget, timelines, and resource allocation to ensure on-time and on-budget delivery of critical assay milestones
Qualification
Required
Ph.D. in Molecular Biology, Genomics, Bioengineering, or a related field
Minimum of 10+ years of progressive experience in assay development within the biotechnology, diagnostics, or life sciences tool industry, with at least 5 years in a senior leadership/management role
Deep technical understanding of complex genomics assays
Direct experience with spatial transcriptomics, multiplexed FISH (like STARmap), in situ sequencing, or similar highly multiplexed imaging/molecular platforms is essential
Proven success taking novel molecular assays from late-stage R&D through formal Verification, Validation, and Commercial Launch
Demonstrated ability to be both a strong, decisive leader and a collaborative, high-EQ team player who contributes to the overall success of the company
A 'can-do' mentality with a fierce commitment to delivering quality assays on time and on budget
Preferred
Experience specifically with thick tissue processing or advanced tissue staining protocols
Familiarity with regulatory requirements (e.g., CLIA/CAP, ISO 13485)
Benefits
An attractive compensation and benefits package based on market pay data
Significant opportunities for professional development and career advancement
Company
Stellaromics Inc.
Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue.
11-50 employees
H1B Sponsorship
Stellaromics Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
Funding
Current Stage
Growth StageTotal Funding
$105MKey Investors
Catalyst4Plaisance Capital Management
2025-02-11Series B· $80M
2023-11-02Series A· $25M
Leadership Team
Ye Fu
Chief Technology Officer and Co-Founder
Recent News
Company data provided by crunchbase